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Background: Human umbilical endothelial cells (HUVECs) are widely used to study the endothelial physiology and
pathology that might be involved in sex and gender differences detected at the cardiovascular level. This study
evaluated whether HUVECs are sexually dimorphic in their morphological, proliferative and migratory properties and
in the gene and protein expression of oestrogen and androgen receptors and nitric oxide synthase 3 (NOS3).
Moreover, because autophagy is influenced by sex, its degree was analysed in male and female HUVECs (MHUVECs
and FHUVECs).
Methods: Umbilical cords from healthy, normal weight male and female neonates born to healthy non-obese and
non-smoking women were studied. HUVEC morphology was analysed by electron microscopy, and their function
was investigated by proliferation, viability, wound healing and chemotaxis assays. Gene and protein expression for
oestrogen and androgen receptors and for NOS3 were evaluated by real-time PCR and Western blotting, respectively,
and the expression of the primary molecules involved in autophagy regulation [protein kinase B (Akt), mammalian
target of rapamycin (mTOR), beclin-1 and microtubule-associated protein 1 light chain 3 (LC3)] were detected
by Western blotting.
Results: Cell proliferation, migration NOS3 mRNA and protein expression were significantly higher in FHUVECs
than in MHUVECs. Conversely, beclin-1 and the LC3-II/LC3-I ratio were higher in MHUVECs than in FHUVECs, indicating
that male cells are more autophagic than female cells. The expression of oestrogen and androgen receptor genes and
proteins, the protein expression of Akt and mTOR and cellular size and shape were not influenced by sex. Body weights
of male and female neonates were not significantly different, but the weight of male babies positively correlated with
the weight of the mother, suggesting that the mother’s weight may exert a different influence on male and female
babies.
Conclusions: The results indicate that sex differences exist in prenatal life and are parameter-specific, suggesting that
HUVECs of both sexes should be used as an in vitro model to increase the quality and the translational value of research.
The sex differences observed in HUVECs could be relevant in explaining the diseases of adulthood because endothelial
dysfunction has a crucial role in the pathogenesis of cardiovascular diseases, diabetes mellitus, neurodegeneration and
immune disease.
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Endothelial cells (ECs) occur in the innermost lining of
all lymphatic and blood vessels. Far from being an inert
layer, the endothelium participates in a large array of
physiological functions, such as the transfer of water, nu-
trients and leukocytes across the vascular wall, innate
and acquired immunity, angiogenesis, control of vaso-
motor tone and maintenance of blood fluidity. Further-
more, it plays an important role in a variety of human
pathologies, including atherosclerosis, diabetes, cardio-
vascular diseases, inflammatory and autoimmune disor-
ders and neurodegeneration [1-4]. Notably, sex-gender
differences are observed in ischemic cardiovascular dis-
eases in women and men [5]. For example, women suffer
a greater extent of endothelial and smooth muscle dysfunc-
tion compared with men [6]. Thus, it has been suggested
that the endothelium might be involved in the establishment
of the sex and gender differences [7] observed in the patho-
physiology of the cardiovascular system [5].
Although sex and gender could affect the outcomes,
interpretation and applicability of data, it is not consist-
ently reported in cell studies [8,9], even when the effects
of sex hormones are analysed [10,11]. Among sex hor-
mones, a central role in the different sex-related inci-
dence of cardiovascular pathologies has been attributed
to oestrogens [12-14]. These hormones participate in the
maintenance of proper endothelial function by increas-
ing the activity of nitric oxide synthase 3 (NOS3) [15].
Oestrogens mediate NOS3 activation, interacting with
oestrogen receptors through both genomic and non-
genomic mechanisms, which involve its protein kinase B
(Akt)-mediated phosphorylation [16], finally leading to
the synthesis of nitric oxide (NO) with vasodilating and
anti-aggregating properties [12].
Human umbilical vein endothelial cells (HUVECs) are
a valuable in vitro model for the study of EC physiology
and pathology [17,18]. Interestingly, when primary cul-
tures of HUVECs obtained from female and male umbilical
cords were studied independently, some sex differences ap-
peared. In particular, thrombin more efficiently stimulated
prostacyclin and prostaglandin E2 synthesis in HUVECs
isolated from male umbilical cords (male human umbilical
vein endothelial cells (MHUVECs)) than in cells obtained
from female umbilical cords (female human umbilical vein
endothelial cells (FHUVECs)) [19], and RLIP76, a Ral
effector GTPase-activating protein, significantly altered
the percentage of apoptosis only in female cells [20].
Further, sex differences have been described in rat and
mouse ECs [21,22].
The aim of this study was to evaluate whether HUVECs
are sexually dimorphic. For this purpose, we analysed the
morphological, proliferative and migratory properties and
the expression of oestrogen and androgen receptors (ERs
and AR, respectively) and NOS3 in male and female cells.Because autophagic processes are influenced by sex in
various cell types and tissues [23-26], we compared the
degree of autophagy and the primary molecules involved
in its regulation, i.e. Akt and the mammalian target of
rapamycin (mTOR), in MHUVECs and FHUVECs. The
results of this study might contribute to a better know-
ledge of the role of endothelium in the sex differences
observed in the physiology and pathophysiology of the
cardiovascular system.
Methods
Donors
Success in culturing human endothelial cells from um-
bilical cords depends not only on culture conditions but
also on factors preceding the harvesting of the cells,
such as birth weight and maternal smoking status [27,28].
Therefore, we selected umbilical cords from healthy hu-
man male and female newborns who were vaginally de-
livered at term (37–42 weeks) at the Obstetrics and
Gynaecology Clinic, University of Sassari, from healthy
non-obese and non-smoking mothers who were drug-
free, with the exception of folic acid and iron supple-
mentation. Only umbilical cords obtained from normal
weight neonates were used to obtain HUVECs. The
normal weight was established according to the Ines
charts described by Bertino et al. [29] (2,430–4,050 g
for females and 2,550–4,190 g for males, that repre-
sented the 10th and 90th centiles in Ines charts). In-
formed consent was obtained from the mothers of all
subjects donating umbilical cords in accordance with
the Declaration of Helsinki.
Cell isolation and characterisation
Primary FHUVECs and MHUVECs were isolated by colla-
genase treatment (Sigma-Aldrich, Milano, Italy), as de-
scribed previously by Crampton et al. [30], and cultured in
plates pre-coated with 1% gelatine (Sigma-Aldrich, Milano,
Italy) in M199 medium (Life Technologies, Monza, Italy)
supplemented with 10% foetal bovine serum (FBS) (Life
Technologies, Monza, Italy), 10% newborn calf serum
(NBCS) (Life Technologies, Monza, Italy), 1% antibiotic/
antimicotic (Sigma-Aldrich, Milano, Italy) and 2 mM of
L-glutamine (Sigma-Aldrich, Milano, Italy) in a 5% CO2
humidified atmosphere. As previously described [31],
cultured cells were characterised as EC by the exhibition
of cobblestone morphology when they were contact-
inhibited and by an evaluation of the expression of von
Willebrand factor, a glycoprotein that is constitutively
stored in intraendothelial Weibel-Palade granules [32].
After seeding (75,000 cells/chamber slide), the cells
were washed with phosphate-buffered saline (PBS) (Sigma-
Aldrich, Milano, Italy) and fixed in 4% paraformalde-
hyde (Sigma-Aldrich, Milano, Italy) for 5 min at room
temperature (RT) and washed in PBS. Then, the cells
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Milano, Italy) for 1 min at RT and washed in PBS before
treatment with blocking solution (PBS +4% bovine serum
albumin (BSA)) (Sigma-Aldrich, Milano, Italy) and 0.1%
Triton X-100 (Sigma-Aldrich, Milano, Italy) for 10 min,
followed by incubation with anti-von Willebrand factor
antibody (Sigma-Aldrich, Milano, Italy) (1:400 dilution in
blocking solution) for 60 min at RT and washed twice with
PBS. The cells were then incubated with anti-rabbit sec-
ondary antibody (Sigma-Aldrich, Milano, Italy) (dilution
1:100 in blocking solution) conjugated with a fluorescent
probe for 30 min in the dark and washed again. Finally,
the nuclei were counterstained with DAPI (Fluka, Sigma-
Aldrich, Milano, Italy) (1 μg/ml) for 4 min in the dark.
After a final wash in PBS, the slides were mounted using a
mounting medium for fluorescence (Vector Laboratories,
Inc., Milano, Italy), and cell images were captured using a
Motic E31 microscope, an in-line digital camera, and the
Motic image plus software.
FHUVECs and MHUVECs were used from passages
3–5 to ensure their endothelial characteristics, and all
experiments were conducted in duplicate or triplicate.
Proliferation, viability, wound healing and chemotaxis
assays
To assess proliferation, FHUVECs (n = 10) and MHU-
VECs (n = 7) were seeded (15,000 cells/cm2 in a 96-well
plate) and cultured from 1 to 7 days. Cell proliferation
was measured by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay (CellTiter 96 AQueous One Solution Cell Pro-
liferation assay, Promega, Milano, Italy) according to the
manufacturer’s instructions. Briefly, 20 μl of MTS solution
was directly added to the wells, and the conversion of MTS
to formazan was recorded in a plate reader (ELx 800UV,
BioTek Instruments Inc., Winooski, USA) at 490 nm after
180 min of incubation at 37°C in a humidified 5% CO2
atmosphere.
Cell viability was determined by trypan blue exclu-
sion using a 0.4% trypan blue solution (Sigma-Aldrich,
Milano, Italy). Viable cells were counted using a Burker
cell counting chamber.
For the wound-healing assay, FHUVECs (n = 9) and
MHUVECs (n = 8) were grown to confluence in gelatine-
coated 12-well plates in complete medium (M199 medium
supplemented with 10% charcoal (Sigma-Aldrich, Milano,
Italy)-stripped FBS, 10% charcoal-stripped NBCS, 1% anti-
biotic/antimicotic and 2 mML-glutamine). The use of
stripped sera allows removing the hormones that it con-
tains, minimising their effects on the migratory capacity of
the cells. When the cells were 90%–100% confluent,
scratches were manually made in the centre of each
well using a p10 pipette tip, and the wells were cultured
for 24 h. Photographs were taken just after scratching andafter 6, 9, 12 and 24 h of incubation at a × 4 magnification.
The percentage of wound closure was calculated using the
ImageProPlus software, measuring the wound area at each
time point in comparison with the initial area measured at
the time of the scratch. Each condition was repeated in
duplicate.
For the chemotaxis assay, HUVECs were suspended in
M199 medium (Life Technologies, Monza, Italy) con-
taining 1% BSA (Sigma-Aldrich, Milano, Italy) and added
to the upper chamber of a 48-well modified Boyden
chamber at a density of 5.0 × 104 cells/well as previously
described [33]. Filters coated with 10 μg/ml of type IV
collagen were placed over a bottom chamber containing
10% FBS as the attractant. After 6 h of incubation at 37°C,
the cells that had migrated to the lower side of the filter
were stained with Diff-Quick stain (VWR Scientific Prod-
ucts, Bridgeport, NJ, USA), and 5 unit fields per filter were
counted using a Zeiss microscope by a scorer blind to the
experimental conditions.
Determination of cellular size and shape
The size and shape of cells [FHUVECs (n = 10) and
MHUVECs (n = 10)] were evaluated on images captured
by an inverted microscope (Zeiss Televal 31, Arese, Italy)
at × 100 using the Labworks software (Labworks 4.0, UVP
Ltd., Cambridge, UK). The cells were photographed in dif-
ferent days of culture (from day 0 to day 14) in at least
seven random fields by placing the multiwell about in
the same position. The perimeter and area were manu-
ally evaluated by an operator who was blinded to the
experiment.
Electron microscopy
FHUVECs (n = 5) and MHUVECs (n = 5) were collected
and washed in PBS, centrifuged at 300 × g for 5 min;
after a second wash in PBS, they were fixed in 2.5% glutar-
aldehyde (Fluka, Sigma-Aldrich, Milano, Italy) for 120 min.
After fixation with 1% osmium tetroxide (Fluka, Sigma-
Aldrich, Milano, Italy), the cells were dehydrated in a series
of graded alcohol solutions, treated with propylene oxide
and then embedded in Durcupan resin (Sigma-Aldrich,
Milano, Italy). Ultrathin sections were double-stained with
uranyl acetate (Sigma-Aldrich, Milano, Italy) and lead cit-
rate (Sigma-Aldrich, Milano, Italy). Sections were exam-
ined under a Zeiss 901 EM.
Determination of H2O2
After 72 h of incubation, the medium obtained from FHU-
VECs (n = 10) and MHUVECs (n = 10) (30,000 cells/cm2)
was collected to measure H2O2 using a commercial kit
(Colorimetric Hydrogen Peroxide kit, Stressgen, Milano,
Italy) following the manufacturer’s instructions. The stand-
ard curve was built by a serial dilution in PBS of a H2O2
standard solution.
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Total protein was measured in cell lysates prepared as
previously described [34]. The protein concentrations
were quantified using the Bradford Protein Assay Reagent
(Sigma-Aldrich, Milano, Italy) following the manufac-
turer’s instructions. The quantification of protein was
determined using a standard curve built with different
concentrations of BSA.
Western blots of actin, NOS3, Akt, mTOR, beclin-1, LC3-I,
LC3-II, ERs and AR
For the Western blot analysis, 30 μg of solubilised protein
was electrophoretically resolved by 4%–15% SDS-PAGE
(100 V, 2 h, 24°C) and then transferred to a PVDF mem-
brane (250 mA, 65 min, 4°C) using a mini-PROTEAN tetra
cell system (Bio-Rad, Milano, Italy). The membranes were
blocked in 5% (w/v) skim milk (Sigma-Aldrich, Milano,
Italy) in Tris buffer (150 mM NaCl (Sigma-Aldrich, Milano,
Italy) and 20 mM Tris–HCl (Sigma-Aldrich, Milano, Italy),
pH 7.2) at 24°C for 1 h and then incubated overnight at
4°C with actin (Sigma-Aldrich, Milano, Italy) (1:1,000), NOS3
(Cell Signaling Technology, Milano, Italy) (1:1,000), Akt (Cell
Signaling Technology, Milano, Italy) (1:1,000), mTOR
(Cell Signaling Technology, Milano, Italy) (1:1,000), beclin-1
(Cell Signaling Technology, Milano, Italy) (1:1,000) or
microtubule-associated protein 1 light chain 3 (LC3-I
and LC3-II) (MBL, Milano, Italy) (1:500), ER-α (Santa
Cruz Biotechnology, Segrate, Italy) (1:100), ER-β (Santa
Cruz Biotechnology, Segrate, Italy) (1:100), GPER30
(K-19)-R: sc-48524-R (Santa Cruz Biotechnology, Segrate,
Italy) (1:100) and AR (C-19): sc-815 (Santa Cruz Biotech-
nology, Segrate, Italy) (1:100) primary antibodies. After
washing to remove excess primary antibody, the blots
were incubated for 1 h with horseradish peroxidase
(HRP)-conjugated secondary antibody (Cell Signaling
Technology, Milano, Italy) (1:2,000). Antibody binding
was detected using an enhanced chemiluminescence
detection system (Cell Signaling Technology, Milano,
Italy). The films were scanned, and the intensity of the
immunoblot bands was detected with area-density soft-
ware (Labworks 4.0, UVP Ltd., Cambridge, UK).
Pilot experiments showed that FHUVECs and MHU-
VECs did not differ in the expression of the housekeeping
protein actin (Cell Signaling Technology, Milano, Italy).
This reference protein was 7,708.99 ± 567.84 OD (n = 35)
and 7,913.24 ± 633.26 OD (n = 31) in FHUVECs and
MHUVECs, respectively. Therefore, it can be used to
normalise the results obtained with other proteins.
NOS3, ERs and AR gene expression
Total RNA was extracted using the RNeasy®Mini Kit
(Qiagen, Hilden, Germany). To avoid DNA contamin-
ation of samples, a 15-min on-column incubation was
carried out with DNase I (Qiagen, Hilden, Germany).Reverse transcription was performed using the Super-
Script III reverse transcriptase (Life Technologies,
Monza, Italy) for NOS3 and β-actin or the High Capacity
cDNA Reverse Transcription Kit for oestrogen and andro-
gen receptors, RPL30 and B2M (Applied Biosystems, CA,
USA). Random RNA samples were always retro-transcribed
with H2O instead of reverse transcriptase (rt-blanks) to
check for genomic amplification during real-time PCR.
The real-time PCR reactions were carried out in dupli-
cate. cDNA (20 ng) was used as template in a total re-
action volume of 10 μl. TaqMan probes were used
[ribosomal protein L30 (RPL30), Hs00265497_m1; beta-2
microglobulin (β2M), Hs99999907_m1; oestrogen recep-
tor 1 (ER-α), Hs00174860_m1; oestrogen receptor 2
(ER-β), Hs01100353_m1*; G protein-coupled oestrogen
receptor (GPER), Hs01922715_s1*; androgen receptor
(AR), Hs00171172_m1*; nitric oxide synthase 3 (NOS3),
Hs00167166_m1; β-actin Hs99999903_m1] according to
the manufacturer’s instructions.
The TaqMan probes were chosen after checking for syn-
onyms in the databases and specificity compared to pseu-
dogenes and isoforms. Where possible, probes straddling
exon junctions were selected. Rt-PCR results for rt-blanks
were always negative. The geometric mean between two
housekeeping genes was used to normalise the real-time
PCR results [35]: the gene that encodes Rpl30, a protein
that is a component of the ribosomal 60S subunit [36],
and the gene that encodes β2M, a component of MHC
class I protein.
For the quantitative analysis of NOS3 gene expression,
we used the ABI PrismH 7000 Sequence Detection System,
SDS software version 1.2.3 (Applied Biosystems, CA,
USA). The results were calculated with the 2−ΔΔCt
method using β-actin as an internal control.
Statistical analysis
Data are displayed as the mean ± SEM if they followed a
Gaussian distribution or as median and median absolute
deviation (MAD) if they were not normally distributed.
Statistical analysis was performed by comparing FHU-
VECs and MHUVECs with unpaired Student’s t-tests or
paired Student’s t-tests when the data followed a normal
distribution, using Sigma-Stat 3.1 software. Non-parametric
variables were compared using the Mann–Whitney rank
sum test and the Wilcoxon signed rank sum test. The
distribution of samples was evaluated by the Kolmogorov-
Smirnov and Shapiro tests. A P ≤ 0.05 was considered sta-
tistically significant. The strength of association between
variables was analysed with the Pearson product moment
correlation coefficient when the data were normally dis-
tributed or with the Spearman product moment correl-
ation coefficient if the data displayed a non-Gaussian
distribution. Differences in the growth rate of FHUVECs
and MHUVECs were assessed using linear regression, in
Table 1 Age and body weight of newborns stratified by
sex
Sex of donors Age of mother
(years)
Weight of
mother(kg)
Body weight of
neonate (kg)
Male (n = 85) 30.93 ± 6.35 71.29 ± 7.67 3.36 ± 0.36
Female (n = 91) 31.96 ± 5.40 70.02 ± 8.32 3.24 ± 0.35
Values are reported as the mean ± SEM of the mothers’ age and weight and
the neonates’ weight. n = sample size.
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of coincidence.
For statistical analysis of real-time data, the Relative
Expression Software Tool (REST©) with 2,000 iterations
was used [37].
Results
Age and weight of mothers and neonates stratified by
sex
Table 1 shows the age and weight of mothers and the
weight of newborns stratified for sex. Mothers of both fe-
male and male babies had very similar ages and weights.
The female babies weighed less than the males, but the
difference did not reach statistical significance.
A highly significant positive correlation was found be-
tween the weight of male newborns and their mother’s
weight (r = 0.389; P = 0.00001), while no significant correl-
ation (r = 0.180; P = 0.0871) was found between the weight
of female newborns and the weight of their mothers
(Figure 1).
Cell proliferation, viability, wound healing and
chemotaxis assays
Growth curves of FHUVECs (n = 10) and MHUVECs
(n = 10) were conducted over a 7-day period, and the
proliferation rates were calculated by plotting the
number of cells against time. The plots revealed a positive
linear correlation in both FHUVECs (r = 0.857; P < 0.0001)
and MHUVECs (r = 0.837; P < 0.0001). The comparison of
slopes (y = 3,452x + 972.8 in FHUVECs; y = 2,708.2x +
1,291.4 in MHUVECs) showed that the proliferationFigure 1 Correlation between neonates and maternal weight (kg) stra
Spearman product moment correlation coefficient and the P value.rate was significantly higher (P < 0.01) in FHUVECs
than in MHUVECs (Figure 2A). The viability of FHU-
VECs and MHUVECs did not present any significant
differences between the sexes (data not shown).
Finally, the basal wound closure capacity of FHUVECs
(n = 9) and MHUVECs (n = 8), which is indicative of cell
migration ability, did not diverge in the first phase of mi-
gration, but after 24 h, it was significantly higher in
FHUVECs than in MHUVECs (P = 0.024) (Figure 2B,C).
When cell motility was evaluated by chemotaxis assays
in the presence of 10% FBS as an attractant, FHUVECs
showed a greater tendency to migrate in comparison
with MHUVECs (data not shown), although this differ-
ence did not reach statistical significance (P = 0.129).
Cellular size, shape and ultrastructure differences
between FHUVECs and MHUVECs
According to Martín de Llano JJ [28], blind analyses of im-
ages captured by an inverted microscope reveal that the
projection area, shape and morphology of FHUVECs and
MHUVECs are not significantly different (data not shown).
However, transmission electron microscopy (Figure 3) re-
vealed that FHUVECs (n = 5) and MHUVECs (n = 5) had a
different ultrastructure pattern. In fact, MHUVECs showed
uniformly distributed pinocytic vesicles on the cellular
membrane surface, a cytoplasm with the usual organelles
and one or two nuclei with nucleoli. Furthermore, the
presence of swollen ribosomes that were mostly enveloped
by lysosomal membranes suggested that the cells were en-
gaged in autophagy.
Lysosomes were filled with heterogeneous material,
suggesting a slow but constant activity. The cells were
not in the same digestive phase: we observed both cells
filled with lysosomes, which is typical of early autoph-
agy, and cells with a dense cytoplasm and almost a
complete absence of organelles, which is typical of late
autophagy. The final stage of autophagy was charac-
terised by a disappearance of cellular organelles, in-
cluding the nucleus. Cellular membranes often showed
breakage points, derangement of the usual double-layertified by sex. (A, B) Each chart contains the equation of the line, the
Figure 2 Proliferation (A) and migration of FHUVECs and
MHUVECs (B, C). Linear regression analysis (A) of the proliferation
of FHUVECs (▲, n = 10) and MHUVECs (▄, n = 7). *The comparison
of the two slopes indicates that the slopes are different (P < 0.001).
(B) Representative photographs of wound closure at 0, 9 and 24 h
taken at × 4 magnification. (C) Mean of basal migratory capacity of
MHUVECs (▄, n = 8) and FHUVECs (▲, n = 9). The data are expressed as
median percentage of wound closure +MAD compared with the
initial area (0 h). *P = 0.024.
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the localisation of pinocytic vesicles on the cellular surface
was eccentric, and the cytoplasm contained lipid vacuoles
that were absent in MHUVECs. The intermediate stages
were associated with a redistribution of vesicles on thewhole cellular surface and with a more electron dense
cytoplasm that was primarily occupied by smooth endo-
plasmic reticulum. Finally, the nuclei of FHUVECs and
MHUVECs had normal membranes and a single or double
nucleolus with small chromatin granules.
H2O2 production
H2O2 is one of the most important reactive oxygen spe-
cies, and its production appears to be sex-dependent in
many mammalian tissues [38]. In line with previous re-
sults, Figure 4 shows that the generation of H2O2 after
72 h of incubation was significantly higher in MHUVECs
(n = 15) than in FHUVECs (n = 15).
NOS3 gene and protein expression
The ability to constitutively produce NO through the ac-
tivity of NOS3 represents an essential feature of ECs. We
therefore evaluated NOS3 gene and protein expression by
RT-qPCR and Western blot, respectively, in male and fe-
male HUVECs (RT-qPCR: FHUVECs (n = 4), MHUVECs
(n = 4); protein levels: FHUVECs (n = 17), MHUVECs
(n = 17)). Figure 5 shows that NOS3 was expressed at a
higher level in female cells than in male cells at both
the mRNA and protein levels (Figure 5A,B).
Expression of autophagic markers: beclin-1, LC3-I and
LC3-II
MHUVECs expressed more beclin-1 in comparison with
FHUVECs (Figure 6A), while the levels of LC3-I and
LC3-II were not significantly different between the groups,
although in FHUVECS, the LC3-I protein showed a ten-
dency to be higher than it was in male cells (data not
shown). However, the ratio LC3-II/LC3-I, an index of
autophagy [39], was significantly higher in MHUVECs
than in FHUVECs (Figure 6B), thus indicating a higher
constitutive autophagy in male cells, as suggested by
the results of ultrastructural studies.
Finally, beclin-1 and LC3-I were positively associated only
in MHUVECs (y = 0.9354x+ 0.8361, r= 0.571, P= 0.0133),
and LC3-I and LC3-II were not associated in both cell types
(data not shown). However, a positive correlation between
LC3-II and the ratio LC3-II/LC3-I was present in MHU-
VECs (y = 1.1799x+ 0.6253, r= 0.688, P < 0.01) and in FHU-
VECs (y = 0.2122x+ 0.3188, r= 0.734, P < 0.00001).
Autophagic processes are influenced by nutrient avail-
ability [40]. We therefore analysed whether beclin-1,
LC3-I, LC3-II and the ratio LC3-II/LC3-I correlated
with the body weight of neonates. Notably, only the expres-
sion of beclin-1 in MHUVECs was negatively associated
with the weight of male newborns (y = −0.1408 + 3.3928,
r = −0.415, P = 0.0285). No significant correlations were
found in FHUVECs among beclin-1, LC3-I, LC3-II and
the ratio LC3-II/LC3-I and the body weight of neonates.
Figure 3 Electron microscopic analysis of FHUVECs and MHUVECs. (A) FHUVECs have little smooth endoplasmic reticulum (SER), abundant
lysosomes (L) and a normal cytoplasmic membrane (CM). M and N indicate the mitochondria and nucleus, respectively. (B) MHUVECs have
abundant autophagic vacuoles (V) in different stages of digestion and a CM with many blebs. M and N indicate the mitochondria and nucleus,
respectively. (A) Magnification × 6,900, scale bars: 2 mm. (B) Magnification × 9,000, scale bars: 2 mm.
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The expression of Akt, an essential survival signalling
protein, and tyrosine kinase mTOR was not different be-
tween the two cell types (Figure 7A,B).
Expression of ERs and AR genes and protein
Whether sex differences can be due to the different ex-
pression of ERs and AR genes was explored. Both FHU-
VECs and MHUVECs expressed genes encoding for ARand ER. As shown in Table 2, genes for AR and classical
ER (ER-α, ER-β) and GPER (formerly GPR30), which seems
to mimic the protective/beneficial effects of oestrogen [41],
were not different between FHUVECs and MHUVECs
(Table 2).
In the same way, the protein expression of AR, ER-α,
ER-β and GPER did not present significant differences
between male and female cells (Figure 8) although GPER
was higher in female than in male.
Figure 4 H2O2 levels in the supernatants obtained from
FHUVECs and MHUVECs. Values are expressed as medians +MAD of
15 independent samples at 72 h (*P = 0.026).
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A significant bench-to-bedside gap has been described
in endothelial biomedicine [18]. Among other reasons,
this could depend on the lack of studies focused on sex
differences in ECs [8]. Here, we show that male and fe-
male HUVECs present some diverse characteristics that
are parameter-specific. The awareness of such sex dif-
ferences could help researchers understand the sexual
differences observed in the incidence, presentation and
outcome of cardiovascular diseases [5] and in other
pathologies such as immune disorders and neurodegen-
eration [3,4].
Globally, our findings show that the expression of
oestrogen and AR genes; the protein expression of Akt,
mTOR, ER-α and ER-β, AR and GPER; and cellular size
and shape are not influenced by sex in HUVECs. However,Figure 5 NOS3 mRNA expression and NOS3 protein expression in FH
values are expressed as the means ± SEM (*P = 0.036) of four independent
densitometric analysis of NOS3 expression. The values are expressed as me
normalised to actin levels.cell proliferation, migratory properties and NOS3 mRNA
and protein expression are higher in FHUVECs than in
MHUVECs. Conversely, beclin-1 and the LC3-II/LC3-I
ratio, two widely accepted markers of autophagy, are
higher in MHUVECs compared to FHUVECs, indicating
that male cells are more prone to undergo autophagy
than female cells. Sex differences in migratory proper-
ties, in oxidative stress and autophagy have been
previously described in rat vascular smooth muscle
cells [38,42].
Conflicting results for ER gene expression are obtained
when experiments are performed in HUVECs without
selection for cell sex. In particular, some authors have
shown that HUVECs did not express the classical gene
for ER-α and/or ER-β [43,44], while other authors have
described the expression of both receptor mRNAs [45,46].
Here, we confirm the presence of both ER-α and ER-β,
thus extending the previous knowledge and evidencing
that FHUVECs and MHUVECs express not only the
classical receptors ER-α and ER-β but also GPER, in a
similar manner. This result is quite surprising because
the ER-α and ER-β genes are differently expressed in
other male and female cell types [23,42,47]. However, a
similar result was reported by Kim-Schulze et al. [48] in
HUVECs.
Moreover, if we considered ER protein expression,
conflicting results are still reported not only when exper-
iments are performed in HUVECs without selection of
sex [45,49,50] but also when gender-related protein ex-
pression is analysed [51]. Annibalini et al. [51] reported
that male and female HUVECs do not express ER-α
while ER-β and AR expression is similar.
On the other hand, some authors describe higher
AR levels in endothelial cells from male but not from
female [52,53].
The lack of significant differences in the expression of
ERs genes and protein in female and male cells does notUVECs and MHUVECs. (A) Relative NOS3 mRNA expression. The
experiments for each sex. (B) Representative Western blot and
dians + MAD (*P < 0.05) of 17 independent experiments for each sex
Figure 6 Beclin-1 and LC3II to LC3I ratio in FHUVECs and MHUVECs. (A) Representative Western blot and densitometric analysis of beclin-1
expression. (B) Ratio of LC3-II to LC3-I and representative Western blot. Values for each protein are expressed as medians + MAD (*P < 0.05) from
at least 18 experiments and normalised to actin levels.
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in XX and XY cells. Interestingly, NOS3 mRNA and its
protein levels, which are regulated by oestrogen through
both non-genomic and genomic mechanisms [15], are
higher in FHUVECs than in MHUVECs. The activity of
NOS3 is also increased by its phosphorylation by Akt
[16]. Here, the expression of Akt protein does not present
a significant sexual dimorphism in HUVECs, contrasting
the previous results in other cells and tissue types [54,55].
In our opinion, the higher level of autophagy observed
in MHUVECs in comparison to FHUVECs is an import-
ant result. This result has been confirmed by ultrastruc-
tural analysis showing a build-up of autophagic vacuoles
at different stages in MHUVECs. These results agree
with some findings obtained in other cell types and tis-
sues, such as cardiac cells, starved rat neurons and starved
embryonic rat fibroblasts and rat cardiac ventricles, where
a higher autophagic response was observed in male
cells or organs [24,25,56]. The male tendency to undergoFigure 7 Akt and mTOR expression levels in FHUVECs and MHUVECs.
expression in FHUVECs and MHUVECs. The values are expressed as median
expression was normalised to actin levels. (B) Representative Western blot
FHUVECs and MHUVECs. The data are the means ± SEM of at least six indepautophagy could depend on increased oxidative behaviour
in MHUVECs compared with FHUVECs, as suggested by
the improved H2O2 production observed in male cells.
The relationship between oxidative stress and constitutive
autophagy is well known but quite complex [57]. Low oxi-
dative stress may increase autophagy [57], and it has re-
cently been observed that an increase in protein oxidation
forces autophagy in cardiac ventricles of male rats in com-
parison with female ones [25].
Sexual divergence of autophagic processes is also sug-
gested by the negative correlation observed between the
expression of beclin-1 in MHUVECs and the weight of
male newborns. According to the literature [58], the
weight of male babies is positively linked to maternal
weight, suggesting that the weight of the mother may
exert a different influence on male and female neonates.
The data also indicate that sex differences begin pre-
natally. Considering the hypothesis of a developmental
origin of adult diseases [59], the sexual differences observed(A) Representative Western blot and densitometric analysis of Akt
s + MAD of at least six independent experiments for each sex. Akt
and densitometric analysis of mTOR expression obtained from
endent experiments for each group normalised to actin.
Table 2 Relative gene expression ratio between
expression level in MHUVECs (n = 8) and FHUVECs (n = 9)
for the oestrogen receptors (ER-α, ER-β and GPER) and
the androgen receptor (AR)
Gene Expression ratio 95% C.I. P (H1)
ER-α 0.811 0.174–4.129 0.556
ER-β 0.900 0.415–2.299 0.564
GPER 1.058 0.145–6.225 0.880
AR 0.870 0.172–2.573 0.648
C.I. confidence interval, P (H1) probability of alternate hypothesis that the
difference between males and females groups is due only to chance.
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adulthood.
One of the most thoroughly studied predictors in the
developmental hypothesis of diseases is birth weight: low
body weight at birth is a risk factor for diabetes mellitus,
while it has been reported that a high birth body weight
predisposes a newborn to cardiovascular diseases [59,60].Figure 8 Protein expression of ERs, GPER and AR in FHUVECs and MH
of ER-α and ER-β expression, respectively, in FHUVECs and MHUVECs. Data
for each group normalised on actin. (C, D) Representative Western blot and
and MHUVECs. Data are reported as medians ± MAD for GPER30 and as
each group normalised on actin.The fact that only the weight of a male newborn is
positively linked to maternal weight describes a com-
plex scenario that suggests the relevance of sex in the
hypothesis of a developmental origin of adult diseases.
Considering the role of autophagy in homeostatic cell
processes and in the development of diseases [61], the
sex differences observed in the autophagic process in
HUVECs could be one of the bases for sex differences
observed in the incidence of adult cardiovascular diseases.Conclusions
In conclusion, these findings indicate that sex differences
are present in prenatal life and are parameter-specific.
This result suggests that HUVECs of both sexes should be
used as an in vitromodel to increase the quality and trans-
lational value of research, in view of the fact that endothe-
lial dysfunction plays a crucial role in the pathogenesis of
cardiovascular diseases, diabetes mellitus, neurodegenera-
tion and immune disease in men and in women.UVECs. (A, B) Representative Western blot and densitometric analysis
are reported as the means ± SEM of at least six independent experiments
densitometric analysis of GPER and AR obtained from FHUVECs
means ± SEM for AR of at least four independent experiments for
Addis et al. Biology of Sex Differences 2014, 5:18 Page 11 of 12
http://www.bsd-journal.com/content/5/1/18Abbreviations
AR: Androgen receptor; Akt: Protein kinase B; BSA: Bovine serum albumin;
ECs: Endothelial cells; ERs: Oestrogen receptors; FBS: Foetal bovine serum;
FHUVECs: Female human umbilical vein endothelial cells; HRP: Horseradish
peroxidase; HUVECs: Human umbilical vein endothelial cells;
LC3: Microtubule-associated protein 1 light chain 3; MHUVECs: Male human
umbilical vein endothelial cells; mTOR: Mammalian target of rapamycin;
MTS: 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium; NBCS: Newborn calf serum; NO: Nitric oxide;
NOS3: Nitric oxide synthase 3; PBS: Phosphate-buffered saline; RT: Room
temperature; SER: Smooth endoplasmic reticulum.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FF conceived and designed the experiments. IC and RA performed the
experiments and statistical analysis and wrote the manuscript. GC and SD
enrolled the subjects, collected the samples and contributed to the
discussions. GF performed the electron microscopy analysis. AM contributed
to the discussions and the electron microscopy analysis. MF, LMV and MGC
performed some experiments and contributed to the discussions. All authors
read and approved the final manuscript.
Acknowledgements
This research was funded by a grant from Regione Sardegna “Progetti di
Farmacovigilanza attiva, finanziabili attraverso i fondi fv 2008/09”. We express
deep gratitude to Novartis Pharma and the Italian Pharmacological Society
for providing the “Gender Innovation” Award to IC. We thank the Mayor of
Osilo for the granting of the structure devoted to the National Laboratory of
Gender Medicine.
Author details
1Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
2National Laboratory of Gender Medicine of the National Institute of
Biostructures and Biosystems, Osilo, Sassari, Italy. 3Department of Surgical,
Microsurgical and Medical Sciences, Gynaecologic and Obstetric Clinic,
University of Sassari, Sassari, Italy. 4Department of Medical Biotechnology and
Translational Medicine, University of Milano, Milano, Italy. 5Assessorato alle
Politiche per la Persona, Region Basilicata, Italy.
Received: 23 June 2014 Accepted: 20 November 2014
References
1. Sena CM, Pereira AM, Seica R: Endothelial dysfunction - a major mediator
of diabetic vascular disease. Biochim Biophys Acta (BBA) - Mol Basis Dis
2013, 1832:2216–2231.
2. Xiao L, Liu Y, Wang N: New paradigms in inflammatory signaling in vascular
endothelial cells. Am J Physiol Heart Circ Physiol 2014, 306:H317–H325.
3. Dai R, Ahmed S: Sexual dimorphism of miRNA expression: a new
perspective in understanding the sex bias of autoimmune diseases.
Ther Clin Risk Manag 2014, 10:151–163.
4. Lyros E, Bakogiannis C, Liu Y, Fassbender K: Molecular links between
endothelial dysfunction and neurodegeneration in Alzheimer’s disease.
Curr Alzheimer Res 2014, 11:18–26.
5. Legato MJ: Principles of Gender-Specific Medicine: 2. 2nd edition. San Diego:
Academic Press; 2009.
6. Papakonstantinou NA, Stamou MI, Baikoussis NG, Goudevenos J, Apostolakis E:
Sex differentiation with regard to coronary artery disease. J Cardiol 2013,
62:4–11.
7. Kublickiene K, Luksha L: Gender and the endothelium. Pharmacol Rep
2008, 60:49–60.
8. Shah K, McCormack CE, Bradbury NA: Do you know the sex of your cells?
Am J Physiol Cell Physiol 2014, 306:C3–C18.
9. Taylor KE, Vallejo-Giraldo C, Schaible N, Zakeri R, Miller V: Reporting of sex
as a variable in cardiovascular studies using cultured cells. Biol Sex Differ
2011, 2:11.
10. Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M,
Meldrum DR: Estrogen receptor beta mediates increased activation of
PI3K/Akt signaling and improved myocardial function in female heartsfollowing acute ischemia. Am J Physiol Regul Integr Comp Physiol 2009,
296:R972–R978.
11. Oviedo PJ, Sobrino A, Laguna-Fernandez A, Novella S, Tarìn JJ, Garcia-Pérez MA,
Sanchìs J, Cano A, Hermenegildo C: Estradiol induces endothelial cell
migration and proliferation through estrogen receptor-enhanced
RhoA/ROCK pathway. Mol Cell Endocrinol 2011, 335:96.
12. Kublickiene K, Fu XD, Svedas E, Landgren BM, Genazzani AR, Simoncini T:
Effects in postmenopausal women of estradiol and medroxyprogesterone
alone and combined on resistance artery function and endothelial
morphology and movement. J Clin Endocrinol Metabol 2008,
93:1874–1883.
13. Reckelhoff JF: Sex and sex steroids in cardiovascular-renal physiology and
pathophysiology. Gender Med 2008, 1(Supplement 1):S1–S2.
14. Regitz-Zagrosek V, Wintermantel TM, Schubert C: Estrogens and SERMs in
coronary heart disease. Curr Opin Pharmacol 2007, 7:130–139.
15. Kypreos KE, Zafirovic S, Petropoulou PI, Bjelogrlic P, Resanovic I, Traish A,
Isenovic ER: Regulation of endothelial nitric oxide synthase and high-density
lipoprotein quality by estradiol in cardiovascular pathology. J Cardiovasc
Pharmacol Ther 2014, 19:256–268.
16. Wu Q, Chambliss K, Umetani M, Mineo C, Shaul PW: Non-nuclear estrogen
receptor signaling in the endothelium. J Biol Chem 2011, 286:14737–14743.
17. Onat D, Brillon D, Colombo P, Schmidt A: Human vascular endothelial
cells: a model system for studying vascular inflammation in diabetes and
atherosclerosis. Current Diabetes Reports 2011, 11:193–202.
18. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS,
Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA,
Schmidt AM, Stern DM: Endothelial cells in physiology and in the
pathophysiology of vascular disorders. Blood 1998, 91:3527–3561.
19. Batres RO, Dupont J: Gender differences in prostacyclin and prostaglandin
E2 synthesis by human endothelial cells. Prostaglandins Leukot Med 1986,
22:159–171.
20. Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C,
Conti F, Riccieri V, Rosano G, Ortona E, Malorni W: Gender disparity in
susceptibility to oxidative stress and apoptosis induced by
autoantibodies specific to RLIP76 in vascular cells. Antioxid Redox Signal
2011, 15:2825–2836.
21. Villar IC, Scotland RS, Khambata RS, Chan M, Duchene J, Sampaio AL, Perretti M,
Hobbs AJ, Ahluwalia A: Suppression of endothelial P-selectin expression
contributes to reduced cell trafficking in females. Arterioscler Thromb
Vasc Biol 2011, 31:1075–1083.
22. Gupta NC, Davis CM, Nelson JW, Young JM, Alkayed NJ: Soluble epoxide
hydrolase: sex differences and role in endothelial cell survival.
Arterioscler Thromb Vasc Biol 2012, 32:1936–1942.
23. Straface E, Vona R, Gambardella L, Ascione B, Marino M, Bulzomi P,
Canu S, Coinu R, Rosano G, Malorni W, Franconi F: Cell sex determines
anoikis resistance in vascular smooth muscle cells. FEBS Lett 2009,
583:3448–3454.
24. Du L, Hickey RW, Bayir H, Watkins SC, Tyurin VA, Guo F, Kochanek PM,
Jenkins LW, Ren J, Gibson G, Chu CT, Kagan VE, Clark RS: Starving neurons
show sex difference in autophagy. J Biol Chem 2009, 284:2383–2396.
25. Campesi I, Straface E, Occhioni S, Montella A, Franconi F: Protein oxidation
seems to be linked to constitutive autophagy: a sex study. Life Sci 2013,
93:145–152.
26. Chen C, Hu LX, Dong T, Wang GQ, Wang LH, Zhou XP, Jiang Y, Murao K, Lu SQ,
Chen JW, Zhang GX: Apoptosis and autophagy contribute to gender
difference in cardiac ischemia-reperfusion induced injury in rats. Life Sci 2013,
93:265–270.
27. Balconi G, Pietra A, Busacca M, de Gaetano G, Dejana E: Success rate of
primary human endothelial cell culture from umbilical cords is
influenced by maternal and fetal factors and interval from delivery.
Vitro 1983, 19:807–810.
28. de Llano JJM, Fuertes G, Torro I, Garcia Vicent C, Fayos JL, Lurbe E: Birth weight
and characteristics of endothelial and smooth muscle cell cultures from
human umbilical cord vessels. J Transl Med 2009, 7:30.
29. Bertino E, Gilli G, Occhi L, Giuliani F, Di Nicola P, Spada E, Fabris C:
Postnatal growth of preterm infants: which reference charts?
Minerva Pediatr 2010, 62(3 Suppl 1):71–74.
30. Crampton SP, Davis J, Hughes CC: Isolation of human umbilical vein
endothelial cells (HUVEC). J Vis Exp 2007, 3:183.
31. Schatz F, Soderland C, Hendricks-Munoz KD, Gerrets RP, Lockwood CJ:
Human endometrial endothelial cells: isolation, characterization, and
Addis et al. Biology of Sex Differences 2014, 5:18 Page 12 of 12
http://www.bsd-journal.com/content/5/1/18inflammatory-mediated expression of tissue factor and type 1 plasminogen
activator inhibitor. Biol Reprod 2000, 62:691–697.
32. Handin RI, Wagner DD: Molecular and cellular biology of von Willebrand
factor. Prog Hemost Thromb 1989, 9:233–259.
33. Cattaneo MG, Cappellini E, Benfante R, Ragni M, Omodeo-Salé F, Nisoli E,
Borgese N, Vicentini LM: Chronic deficiency of nitric oxide affects hypoxia
inducible factor-1a (HIF-1a) stability and migration in human endothelial
cells. PLoS One 2011, 6:e29680.
34. Sapan CV, Lundblad RL, Price NC: Colorimetric protein assay techniques.
Biotechnol Appl Biochem 1999, 29:99–108.
35. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A,
Speleman F: Accurate normalization of real-time quantitative RT-PCR data
by geometric averaging of multiple internal control genes. Genome Biol
2002, 3:research0034.0031-research0034.0011.
36. de Jonge HJM, Fehrmann RSN, de Bont ESJM, Hofstra RMW, Gerbens F,
Kamps WA, de Vries EGE, van der Zee AGJ, te Meerman GJ, ter Elst A:
Evidence based selection of housekeeping genes. PLoS One 2007, 2:e898.
37. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool
(RESTÂ©) for group-wise comparison and statistical analysis of relative
expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36.
38. Malorni W, Campesi I, Straface E, Vella S, Franconi F: Redox features of the
cell: a gender perspective. Antioxid Redox Signal 2007, 9:1779–1801.
39. Ma XH, Piao S, Wang D, McAfee QW, Nathanson KL, Lum JJ, Li LZ,
Amaravadi RK: Measurements of tumor cell autophagy predict
invasiveness, resistance to chemotherapy, and survival in melanoma.
Clin Cancer Res 2011, 17:3478–3489.
40. Rabinowitz JD, White E: Autophagy and metabolism. Science 2010,
330:1344–1348.
41. Prossnitz ER, Barton M: Estrogen biology: new insights into GPER function
and clinical opportunities. Mol Cell Endocrinol 2014, 389:71–83.
42. Pellegrini M, Bulzomi P, Lecis M, Leone S, Campesi I, Franconi F, Marino M:
Endocrine disruptors differently influence estrogen receptor β and
androgen receptor in male and female rat VSMC. J Cell Physiol 2014,
229:1061–1068.
43. Hervé MAJ, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S,
Perrot-Applanat M: Regulation of the vascular endothelial growth
factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in
uterus. J Endocrinol 2006, 188:91–99.
44. Toth B, Saadat G, Geller A, Scholz C, Schulze S, Friese K, Jeschke U: Human
umbilical vascular endothelial cells express estrogen receptor beta (ERβ)
and progesterone receptor A (PR-A), but not ERα and PR-B. Histochem Cell
Biol 2008, 130:399.
45. Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ: Estrogen receptors
a and b have similar activities in multiple endothelial cell pathways.
Endocrinology 2002, 143:3785–3795.
46. Laughlin MH, Welshons WV, Sturek M, Rush JW, Turk JR, Taylor JA, Judy BM,
Henderson KK, Ganjam V: Gender, exercise training, and eNOS expression
in porcine skeletal muscle arteries. J Appl Physiol 2003, 95:250–264.
47. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB: Estrogen receptor in
the human eye: influence of gender and age on gene expression.
Invest Ophthalmol Vis Sci 1999, 40:1906–1911.
48. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK,
Greene GL, Schnaper HW: Expression of an estrogen receptor by human
coronary artery and umbilical vein endothelial cells. Circulation 1996,
94:1402–1407.
49. Greaves E, Collins F, Critchley HOD, Saunders PTK: ERb-dependent effects
on uterine endothelial cells are cell specific and mediated via Sp1.
Hum Reprod 2013, 28:2490–2501.
50. Simard M, Drolet R, Blomquist C, Tremblay Y: Human type 2 17beta-
hydroxysteroid dehydrogenase in umbilical vein and artery endothelial
cells: differential inactivation of sex steroids according to the vessel type.
Endocrine 2011, 40:203–211.
51. Annibalini G, Agostini D, Calcabrini C, Martinelli C, Colombo E, Guescini M,
Tibollo P, Stocchi V, Sestili P: Effects of sex hormones on inflammatory
response in male and female vascular endothelial cells. J Endocrinol
Investig 2014, 37:861–869.
52. Death AK, McGrath KCY, Sader MA, Nakhla S, Jessup W, Handelsman DJ,
Celermajer DS: Dihydrotestosterone promotes vascular cell adhesion
molecule-1 expression in male human endothelial cells via a nuclear
factor-kappaB-dependent pathway. Endocrinology 2004, 145:1889–1897.53. McGrath K, Hill M, Mcrobb L, Heather A: The androgen receptor drives the
sex-specific expression of vascular cell adhesion molecule-1 in endothelial
cells but not lipid metabolism genes in monocyte-derived macrophages.
Horm Mol Biol Clin Invest 2010, 2:203–209.
54. Bae S, Zhang L: Gender differences in cardioprotection against ischemia/
reperfusion injury in adult rat hearts: focus on Akt and protein kinase C
signaling. J Pharmacol Exp Ther 2005, 315:1125–1135.
55. Wang F, He Q, Sun Y, Dai X, Yang XP: Female adult mouse cardiomyocytes
are protected against oxidative stress. Hypertension 2010, 55:1172–1178.
56. Le TYL, Ashton AW, Mardini M, Stanton PG, Funder JW, Handelsman DJ,
Mihailidou AS: Role of androgens in sex differences in cardiac damage
during myocardial infarction. Endocrinology 2014, 155:568–575.
57. Lee J, Giordano S, Zhang J: Autophagy, mitochondria and oxidative stress:
cross-talk and redox signalling. Biochem J 2012, 441:523–540.
58. Cuestas E, Darauich L, Corredera L, Costa ME: Is there any correlation
between mothers birth weight with the first child birth weight? Rev Fac
Cien Med Univ Nac 2007, 3:68–72.
59. Hales CN, Barker DJP: The thrifty phenotype hypothesis: type 2 diabetes.
Br Med Bull 2001, 60:5–20.
60. Zhang Y, Li H, Liu S, Fu G, Zhao Y, Xie YJ, Zhang Y, Wang Y: The associations
of high birth weight with blood pressure and hypertension in later life: a
systematic review and meta-analysis. Hypertens Res 2013, 36:725–735.
61. Murrow L, Debnath J: Autophagy as a stress-response and quality-control
mechanism: implications for cell injury and human disease. Annu Rev
Pathol 2013, 8:105–137.
doi:10.1186/s13293-014-0018-2
Cite this article as: Addis et al.: Human umbilical endothelial cells
(HUVECs) have a sex: characterisation of the phenotype of male and
female cells. Biology of Sex Differences 2014 5:18.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
